IR-101H

N/A

Report date: 2025/01/26 19:28:26

Base Information

Drug NameIR-101H
Drug Alias NameLivaVaxhepatitis A/B/C vaccine (Immune Response)IR-101H LivaVaxTCR peptide vaccine (Immune Response)IR-101H
ClassificationVaccinesBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulatorsT lymphocytes modulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis CHepatitis AHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmune Response Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmune Response Biopharma Inc
Inactive CompaniesN/A
Active IndicationsHepatitis CHepatitis AHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A